RxDoctor Payments Data

Heather Hart, MD

Family Medicine · Souderton, PANPI 1871532036

Payments from drug & device makers

$2,122in general payments, 2019–2025

Across 132 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$402
  • Pfizer$398
  • Novo Nordisk$276
  • Johnson & Johnson$162
  • Astellas Pharma US Inc$138
  • GSK$130
  • plus $616 from 16 others

What the payments were for

  • Food & beverage$2,122100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,122 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$132,375
Medicare patients
362
Services billed
2,581

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban58$32,791
JardianceEmpagliflozin23$19,960
MyrbetriqMirabegron31$19,330
OzempicSemaglutide12$12,696
JanuviaSitagliptin Phosphate13$12,436
Formoterol Fumarate12$10,930
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$10,863
XareltoRivaroxaban13$9,145
Spiriva RespimatTiotropium Bromide13$6,673
Aripiprazole24$5,981
Tresiba Flextouch U-100Insulin Degludec11$5,221
RestasisCyclosporine17$4,613
ArexvyRsvpref3 Antigen/As01e/Pf14$4,363
Levothyroxine Sodium362$3,989
Atorvastatin Calcium335$3,538

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$398$32,79158 claims
Astellas Pharma US IncMyrbetriq$138$19,33031 claims
Novo NordiskOzempic$276$12,69612 claims
MerckJanuvia$38$12,43613 claims
Johnson & JohnsonXarelto$162$9,14513 claims
AbbVieRestasis, Synthroid$402$6,97154 claims
GSKArexvy$130$4,36314 claims
AstraZenecaSymbicort$66$2,86013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Souderton

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →